Is LNAI or LXEO more undervalued in 2026?

CirclFi compares Lunai Bioworks Inc. (LNAI) and Lexeo Therapeutics, Inc. (LXEO) using 13 institutional-grade valuation models. LNAI has a Quality of Company score of 2.9/10 while LXEO scores 4.5/10.

Which is a better buy — LNAI or LXEO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do LNAI and LXEO valuations compare?

LNAI at $3.04 and LXEO at $5.08 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

LNAI vs LXEO Valuation Comparison 2026 — Intrinsic Value Analysis

LNAI

Biotechnology

Lunai Bioworks Inc.

Quality

2.9

out of 10

Value Trap

WARN

Price

$3.04

Last close

Models

5/13

Active

LXEO

Biotechnology

Lexeo Therapeutics, Inc.

Quality

4.5

out of 10

Value Trap

SAFE

Price

$5.08

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	LNAI Fair Value	LNAI Upside	LXEO Fair Value	LXEO Upside
Bayesian DCF	Intrinsic	$0.84	-72.4%	$1.83	-64.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	—	—	$2.81	-44.7%
PWERM	Option-Based	$6.31	+107.4%	$4.99	-1.8%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for LNAI vs LXEO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

LNAI vs LXEO — Which Stock Is More Undervalued?

LXEO scores higher with a 4.5/10 quality rating vs LNAI's 2.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Lunai Bioworks Inc. (LNAI) and Lexeo Therapeutics, Inc. (LXEO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

LNAI currently trades at $3.04 with a QOC of 2.9/10, while LXEO trades at $5.08 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).